E. Galíndez

947 total citations
21 papers, 117 citations indexed

About

E. Galíndez is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, E. Galíndez has authored 21 papers receiving a total of 117 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 10 papers in Immunology and 7 papers in Hematology. Recurrent topics in E. Galíndez's work include Spondyloarthritis Studies and Treatments (14 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). E. Galíndez is often cited by papers focused on Spondyloarthritis Studies and Treatments (14 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). E. Galíndez collaborates with scholars based in Spain, United States and France. E. Galíndez's co-authors include Loreto Carmona, Jordi Gratacós, Teresa Otón, Cristina Fernández‐Carballido, Raquel Almodóvar, Julio Ramírez, Estéban Rubio, L. Linares, Jesús Luelmo and Pablo Coto and has published in prestigious journals such as Annals of the Rheumatic Diseases, Rheumatology International and RMD Open.

In The Last Decade

E. Galíndez

18 papers receiving 116 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Galíndez Spain 6 98 70 40 13 8 21 117
Musaab Elmamoun United Kingdom 5 63 0.6× 64 0.9× 38 0.9× 4 0.3× 3 0.4× 8 94
Laurence Carton France 4 99 1.0× 59 0.8× 29 0.7× 4 0.3× 6 0.8× 12 110
Mette Holland‐Fischer Denmark 5 212 2.2× 172 2.5× 102 2.5× 3 0.2× 6 0.8× 8 242
Olga Ziouzina Canada 3 95 1.0× 65 0.9× 35 0.9× 2 0.2× 3 0.4× 5 98
Heidi Bertheussen United States 5 40 0.4× 37 0.5× 13 0.3× 3 0.2× 10 1.3× 10 66
José Manuel Rodríguez Heredia Spain 5 56 0.6× 13 0.2× 19 0.5× 3 0.2× 2 0.3× 11 71
Estéban Rubio Spain 6 45 0.5× 32 0.5× 22 0.6× 14 1.8× 12 63
Cristina Campos Spain 6 66 0.7× 29 0.4× 29 0.7× 2 0.2× 5 0.6× 12 79
Tomas Husmark Sweden 5 274 2.8× 208 3.0× 142 3.5× 3 0.2× 4 0.5× 7 288
Zaki United States 3 29 0.3× 59 0.8× 8 0.2× 9 0.7× 7 0.9× 7 97

Countries citing papers authored by E. Galíndez

Since Specialization
Citations

This map shows the geographic impact of E. Galíndez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Galíndez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Galíndez more than expected).

Fields of papers citing papers by E. Galíndez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Galíndez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Galíndez. The network helps show where E. Galíndez may publish in the future.

Co-authorship network of co-authors of E. Galíndez

This figure shows the co-authorship network connecting the top 25 collaborators of E. Galíndez. A scholar is included among the top collaborators of E. Galíndez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Galíndez. E. Galíndez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Montero, David, L. Fuertes, Cynthia Pérez, et al.. (2021). AB0151 FOLLOW-UP IN A MULTIDISCIPLINARY UNIT IMPROVES PREGNANCY OUTCOME IN INFLAMMATORY ARTHROPATIES ON BIOLOGICAL THERAPY. Annals of the Rheumatic Diseases. 80. 1103–1103. 1 indexed citations
3.
Fuertes, L., et al.. (2021). AB0153 REAL LIFE SEVERE INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON TREATMENT WITH BIOLOGICAL THERAPY AND JAKI. Annals of the Rheumatic Diseases. 80. 1104–1104. 1 indexed citations
4.
Fernández‐Carballido, Cristina, Carmen Castro, E. Galíndez, et al.. (2020). No radiographic sacroiliitis progression was observed in patients with early spondyloarthritis at 6 years: results of the Esperanza multicentric prospective cohort. RMD Open. 6(2). e001345–e001345. 5 indexed citations
5.
Miguel, Eugenio de, et al.. (2020). SAT0369 SPINAL RADIOGRAPHIC PROGRESSION IN EARLY SPONDYLOARTHRITIS: SIX-YEAR RESULTS FROM THE ESPERANZA COHORT. Annals of the Rheumatic Diseases. 79. 1132–1132. 1 indexed citations
6.
Gratacós, Jordi, E. Galíndez, & Teresa Otón. (2020). Is obesity a predictor for lack of response to treatment in psoriatic arthritis? A systematic review. Reumatología Clínica (English Edition). 17(5). 268–278. 6 indexed citations
7.
Montero, David, et al.. (2020). AB1167 PREGNANCY AND INFLAMMATORY ARTHROPATIES: EXPERIENCE IN A MULTIDISCIPLINARY UNIT. Annals of the Rheumatic Diseases. 79. 1874–1874.
8.
Tony, Hans‐Peter, E. Galíndez, Chen‐Yen Lin, et al.. (2019). SAT0396 IMPROVEMENT IN THE SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS WITH IXEKIZUMAB COMPARED TO PLACEBO IN PATIENT SUBGROUPS DEFINED BY BASELINE DISEASE CHARACTERISTICS. Annals of the Rheumatic Diseases. 78. 1285–1285. 3 indexed citations
9.
Gratacós, Jordi, E. Galíndez, & Teresa Otón. (2019). ¿Es la obesidad un factor predictivo de falta de respuesta al tratamiento en la artritis psoriásica? Actualización de una revisión sistemática. Reumatología Clínica. 17(5). 268–278. 5 indexed citations
10.
Montero, David, L. Fuertes, Eduardo Cuende, et al.. (2019). SAT0320 FREQUENCY AND CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASE IN SPONDYLOARTHRITIS WITH BIOLOGICAL THERAPY. STUDY OF 270 PATIENTS FROM THE SAME CENTER. Annals of the Rheumatic Diseases. 78. 1238–1239.
11.
Sanz, Jesús, E. Beltrán, Cristina Fernández‐Carballido, et al.. (2019). Quality standard for the management of patients with psoriatic arthritis: QUANTUM project. Reumatología Clínica (English Edition). 16(3). 203–215. 5 indexed citations
12.
Almodóvar, Raquel, Loreto Carmona, Ana Urruticoechea‐Arana, et al.. (2018). The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot study. Rheumatology International. 38(7). 1277–1284. 3 indexed citations
13.
Deza, Gustavo, J. Notario, Marta Ferrán, et al.. (2018). Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain. Rheumatology International. 38(11). 2037–2043. 3 indexed citations
14.
Sanz, Jesús, E. Beltrán, Cristina Fernández‐Carballido, et al.. (2018). Norma de calidad para el manejo del paciente con artritis psoriásica: proyecto QUANTUM. Reumatología Clínica. 16(3). 203–215. 9 indexed citations
15.
Otón, Teresa, Estíbaliz Loza, E. Beltrán, et al.. (2018). AB1269 Quality standard for the management of patients with psoriatic arthritis: quantum project. Annals of the Rheumatic Diseases. 77. 1728–1729. 1 indexed citations
16.
Torre‐Alonso, Juan Carlos, Loreto Carmona, Mireia Moreno, et al.. (2017). Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain. Rheumatology International. 37(8). 1239–1248. 21 indexed citations
17.
Gorostiza, Iñigo, et al.. (2017). THU0109 Updated estimation of the EQ5D quality of life questionnaire utility values through HAQ-DI mapping for spain. Annals of the Rheumatic Diseases. 76. 241–242. 1 indexed citations
18.
Galíndez, E. & Loreto Carmona. (2016). ¿Se asocia la obesidad en la artritis psoriásica a una menor respuesta terapéutica y más efectos adversos con el tratamiento de fondo?. Reumatología Clínica. 12(6). 307–312. 25 indexed citations
19.
Galíndez, E. & Loreto Carmona. (2016). Is Obesity in Psoriatic Arthritis Associated With a Poorer Therapeutic Response and More Adverse Effects of Treatment With an Anchor Drug?. Reumatología Clínica (English Edition). 12(6). 307–312. 23 indexed citations
20.
Galíndez, E., et al.. (1996). [Chronic monoarthritis caused by osteoid osteoma].. PubMed. 13(7). 344–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Musaab Elmamoun Breakdown of academic impact, for papers by Laurence Carton Breakdown of academic impact, for papers by Mette Holland‐Fischer Breakdown of academic impact, for papers by Olga Ziouzina Breakdown of academic impact, for papers by Heidi Bertheussen Breakdown of academic impact, for papers by José Manuel Rodríguez Heredia Breakdown of academic impact, for papers by Estéban Rubio Breakdown of academic impact, for papers by Cristina Campos Breakdown of academic impact, for papers by Tomas Husmark Breakdown of academic impact, for papers by Zaki
Rankless by CCL
2026